EGLBX
Price
$28.62
Change
-$0.05 (-0.17%)
Updated
Dec 2 closing price
Net Assets
165.24M
MDIHX
Price
$27.92
Change
+$0.03 (+0.11%)
Updated
Dec 2 closing price
Net Assets
43.71B
Interact to see
Advertisement

EGLBX vs MDIHX

Header iconEGLBX vs MDIHX Comparison
Open Charts EGLBX vs MDIHXBanner chart's image
Elfun International Equity
Price$28.62
Change-$0.05 (-0.17%)
VolumeN/A
Net Assets165.24M
MFS Intl Diversification R3
Price$27.92
Change+$0.03 (+0.11%)
VolumeN/A
Net Assets43.71B
EGLBX vs MDIHX Comparison Chart in %
View a ticker or compare two or three
VS
EGLBX vs. MDIHX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EGLBX is a Buy and MDIHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MDIHX has more cash in the bank: 43.7B vs. EGLBX (165M). MDIHX pays higher dividends than EGLBX: MDIHX (1.84) vs EGLBX (1.39). EGLBX was incepted earlier than MDIHX: EGLBX (38 years) vs MDIHX (21 years). MDIHX (1.10) is less costly to investors than EGLBX (0.38). EGLBX is a more actively managed with annual turnover of: 12.00 vs. MDIHX (2.00). MDIHX has a lower initial minimum investment than EGLBX: MDIHX (0) vs EGLBX (500). MDIHX annual gain was more profitable for investors over the last year : 20.46 vs. EGLBX (10.84). MDIHX return over 5 years is better than : 30.03 vs. EGLBX (21.72).
EGLBXMDIHXEGLBX / MDIHX
Total Expense Ratio0.381.0835%
Annual Report Gross Expense Ratio0.381.1035%
Fund Existence38 years21 years-
Gain YTD19.40924.84378%
Front LoadN/AN/A-
Min. Initial Investment5000-
Min. Initial Investment IRAN/AN/A-
Net Assets165M43.7B0%
Annual Yield % from dividends1.391.8475%
Returns for 1 year10.8420.4653%
Returns for 3 years31.6641.0077%
Returns for 5 years21.7230.0372%
Returns for 10 years67.55106.7963%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGOAX46.75N/A
N/A
Patient Opportunity A
ANCIX15.23N/A
N/A
Ancora MicroCap I
HFQIX7.21N/A
N/A
Janus Henderson Global Equity Income I
TASMX30.16N/A
N/A
Transamerica Small/Mid Cap Value R6
TRDIX8.65N/A
N/A
Transamerica Sustainable Equity Inc I2